Abingworth

Abingworth as of March 31, 2012

Portfolio Holdings for Abingworth

Abingworth holds 22 positions in its portfolio as reported in the March 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Amarin Corporation 44.9 $89M 7.9M 11.31
Clovis Oncology 16.5 $33M 1.3M 25.19
Alnylam Pharmaceuticals (ALNY) 10.1 $20M 1.8M 11.06
Incyte Corporation (INCY) 8.1 $16M 830k 19.30
Astex Pharmaceuticals 4.2 $8.3M 4.5M 1.86
OncoGenex Pharmaceuticals 4.0 $8.0M 604k 13.29
Nektar Therapeutics (NKTR) 2.6 $5.3M 664k 7.92
Zogenix 2.3 $4.6M 2.3M 1.98
ISIS Pharmaceuticals 1.2 $2.3M 268k 8.78
Exelixis (EXEL) 1.1 $2.1M 415k 5.18
Novavax 1.0 $1.9M 1.5M 1.27
Celldex Therapeutics 0.9 $1.7M 343k 5.09
Alexza Pharmaceuticals 0.9 $1.7M 2.9M 0.60
Isis Pharmaceuticals Inc Del note 2.625% 2/1 0.6 $1.2M 1.3k 970.31
Zalicus 0.5 $1.0M 864k 1.20
Cornerstone Therapeutics 0.2 $505k 85k 5.96
Allos Therapeutics 0.2 $392k 265k 1.48
Sunesis Pharmaceuticals 0.2 $370k 129k 2.86
AVANIR Pharmaceuticals 0.2 $385k 113k 3.42
Cardiome Pharma Corp 0.2 $337k 481k 0.70
EntreMed 0.1 $149k 71k 2.11
Poniard Pharmaceuticals (PARD) 0.0 $10k 4.6k 2.19